Studies have shown that PCV is highly effective in preventing pneumococcal diseases. The vaccine has led to a significant decline in invasive pneumococcal diseases, including a reduction in cases of pneumococcal meningitis and bacteremia by over 90% in vaccinated populations. Additionally, the vaccine contributes to herd immunity, protecting those who are not vaccinated by reducing the overall prevalence of the bacteria.
